Skip to main content

Table 1 Effect of dopamine 1/5 receptor agonist treatment on skeletal muscle cAMP levels.

From: Activation of the dopamine 1 and dopamine 5 receptors increase skeletal muscle mass and force production under non-atrophying and atrophying conditions

Treatment

Tibialis Anterior cAMP

levels +/- SEM

(femptomoles/mg)

Medial Gastrocnemius

cAMP levels +/- SEM

(femptomoles/mg)

Theophylline

329.6 +/- 62.6

286.4 +/-58.8

SKF 81297 + theophylline

486.6 +/- 81.4*

535.3 +/-53.6*

  1. * - statistically significant (p < 0.05) versus theophylline.
Back to article page

BMC Musculoskeletal Disorders

ISSN: 1471-2474

Contact us